Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2851000
Reference Type
Journal Article
Title
Temporal changes (1997-2012) of perfluoroalkyl acids and selected precursors (including isomers) in Swedish human serum
Author(s)
Gebbink, WA; Glynn, A; Berger, U
Year
2015
Is Peer Reviewed?
Yes
Journal
Environmental Pollution
ISSN:
0269-7491
EISSN:
1873-6424
Publisher
ELSEVIER SCI LTD
Location
OXFORD
Volume
199
Page Numbers
166-173
Language
English
PMID
25660070
DOI
10.1016/j.envpol.2015.01.024
Web of Science Id
WOS:000351972900021
Abstract
Concentrations (including isomer patterns) and temporal changes (1997-2012) of perfluoroalkyl acids (PFAAs) and selected perfluorooctane sulfonate (PFOS) and perfluoroalkyl carboxylic acid (PFCA) precursors were determined in serum samples from Swedish women. Perfluorooctane sulfonamide (FOSA) and perfluorooctane sulfonamidoacetic acid (FOSAA), as well as its N-methyl and N-ethyl derivatives (MeFOSAA and EtFOSAA) were consistently detected. Highest PFOS precursor concentrations were found for EtFOSAA (before year 2000) or MeFOSAA and FOSAA (after 2000). Disappearance half-lives for all PFOS precursors were shorter compared to PFOS. 4:2/6:2 and 6:2/6:2 polyfluoroalkyl phosphate diesters (diPAPs) were detected in <60% of the samples, whereas 6:2/8:2 and 8:2/8:2 diPAPs were detected in >60% of the samples, but showed no significant change in concentrations over time. Linear and sum-branched isomers were quantified separately for three PFAAs and three precursors. Significant changes between 1997 and 2012 in the % linear isomer were observed for PFOA and FOSA (increase) and PFOS (decrease).
Keywords
per- and polyfluoroalkyl substances; precursors; human serum; temporal trend; PAPs; isomers
Tags
PFAS
•
6:2/8:2 diPAP
Literature Search
Pubmed
WOS
Screening Results
Excluded/Not on Topic
•
6:2 diPAP
Literature Search
Pubmed
WOS
Screening Results
Excluded/Not on Topic
•
8:2 diPAP
Literature Search
Pubmed
WOS
Screening Results
Excluded/Not on Topic
•
Additional PFAS (formerly XAgency)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch: September 2019
PubMed
Web of Science
Screened Studies
Supplemental
Perfluorooctane
2-(N-Ethylperfluorooctanesulfonamido)acetic acid
2-(N-Methylperfluorooctanesulfonamido)acetic acid
•
^Per- and Polyfluoroalkyl Substances (PFAS)
PFOA (335-67-1) and PFOS (1763-23-1)
Literature Search – Adverse outcome pathway (2015-present)
Pubmed
WOS
PFOSA (754-91-6)
Literature Search
WOS
6:2 diPAP (57677-95-9)
Literature Search
Pubmed
WOS
8:2 diPAP (678-41-1)
Literature Search
Pubmed
WOS
6:2/8:2 diPAP (943913-15-3)
Literature Search
Pubmed
WOS
•
PFAS 150
Literature Search Update December 2020
PubMed
WOS
Literature Search August 2019
PubMed
Web of Science
Not prioritized for screening
Perfluorinated compounds
Perfluorooctane
Perfluorooctanesulfonate
Perfluorooctanesulfonic acid
•
PFOA (335-67-1) and PFOS (1763-23-1)
Literature Search – Adverse outcome pathway (2015-present)
Pubmed
WOS
Screening Results
Excluded/Not on Topic
Literature Search Update (2013-2019)
PubMed
WOS
•
PFOSA
Literature Search
Pubmed
WOS
Screening Results
Excluded/Not on Topic
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity